DE60016775D1 - Hybride matrizen und gemische davon - Google Patents
Hybride matrizen und gemische davonInfo
- Publication number
- DE60016775D1 DE60016775D1 DE60016775T DE60016775T DE60016775D1 DE 60016775 D1 DE60016775 D1 DE 60016775D1 DE 60016775 T DE60016775 T DE 60016775T DE 60016775 T DE60016775 T DE 60016775T DE 60016775 D1 DE60016775 D1 DE 60016775D1
- Authority
- DE
- Germany
- Prior art keywords
- microcarriers
- polypeptide
- animal
- mixtures
- vertebrate cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/438—Antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Polyurethanes Or Polyureas (AREA)
- Dental Preparations (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/413,715 US6419920B1 (en) | 1995-10-25 | 1999-10-05 | Hybrid matrix implants and explants |
US66203700A | 2000-09-14 | 2000-09-14 | |
PCT/US2000/027362 WO2001024842A2 (en) | 1999-10-05 | 2000-10-04 | Hybrid matrices and hybrid matrix mixtures |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60016775D1 true DE60016775D1 (de) | 2005-01-20 |
Family
ID=27022280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60016775T Expired - Lifetime DE60016775D1 (de) | 1999-10-05 | 2000-10-04 | Hybride matrizen und gemische davon |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1221937B1 (de) |
JP (1) | JP2003511100A (de) |
CN (1) | CN1214781C (de) |
AT (1) | ATE284674T1 (de) |
AU (1) | AU777833B2 (de) |
BR (1) | BR0014503A (de) |
CA (1) | CA2379971A1 (de) |
DE (1) | DE60016775D1 (de) |
HK (1) | HK1047240B (de) |
IL (1) | IL148962A0 (de) |
MX (1) | MXPA02001450A (de) |
NZ (1) | NZ518759A (de) |
TR (1) | TR200200897T2 (de) |
WO (1) | WO2001024842A2 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030039695A1 (en) * | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
US9034315B2 (en) | 1997-10-10 | 2015-05-19 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Cell-charged multi-layer collagen membrane |
US20050186283A1 (en) | 1997-10-10 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
US8858981B2 (en) | 1997-10-10 | 2014-10-14 | Ed. Geistlich Soehne Fuer Chemistrie Industrie | Bone healing material comprising matrix carrying bone-forming cells |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
US6673603B2 (en) | 2000-09-01 | 2004-01-06 | Modex Therapeutiques, S.A. | Cell paste comprising keratinocytes and fibroblasts |
AR034262A1 (es) * | 2000-09-14 | 2004-02-18 | Transkaryotic Therapies Inc | Una composicion para proporcionar una mezcla fluida inyectable, un equipo, un metodo para preparacion de una mezcla de dicho equipo, un aparato para la introduccion de una mezcla en un paciente |
TWI221421B (en) * | 2001-05-17 | 2004-10-01 | Gejyo Fumitake | Artificial kidney having function of metabolizing protein and method of constructing the same |
US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
CN1294994C (zh) * | 2004-07-05 | 2007-01-17 | 暨南大学 | 可注射型胶原基软组织填充材料及其制备方法 |
ES2490610T3 (es) * | 2004-12-08 | 2014-09-04 | Shire Regenerative Medicine, Inc. | Materiales y métodos para la administración mínimamente invasiva de una composición fluida que contiene células |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
GB0524103D0 (en) | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
US7671014B2 (en) * | 2006-08-14 | 2010-03-02 | Warsaw Orthopedic, Inc. | Flowable carrier matrix and methods for delivering to a patient |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US9616153B2 (en) | 2008-04-17 | 2017-04-11 | Warsaw Orthopedic, Inc. | Rigid bone graft substitute |
US9889230B2 (en) * | 2008-10-17 | 2018-02-13 | Covidien Lp | Hemostatic implant |
US8034363B2 (en) | 2008-12-11 | 2011-10-11 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release systems of ascorbic acid phosphate |
US8980248B2 (en) | 2009-12-18 | 2015-03-17 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
WO2011126294A2 (ko) * | 2010-04-06 | 2011-10-13 | 동국대학교 산학협력단 | 콜라겐 하이드로겔 제조용 멀티 시린지 |
FR2960783B1 (fr) * | 2010-06-04 | 2012-07-27 | Ass Pour Les Transferts De Technologies Du Mans | Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane |
DE102011011092A1 (de) * | 2011-02-09 | 2012-08-23 | Amedrix Gmbh | Gelierendes Kollagen und Mittel zu dessen Bereitstellung |
KR101266652B1 (ko) * | 2011-10-19 | 2013-05-22 | 국립대학법인 울산과학기술대학교 산학협력단 | 하이드로젤을 이용한 세포 패터닝 및 전달 방법 및 이를 이용한 세포 기반 바이오센서 |
DE102012213496A1 (de) | 2012-07-31 | 2014-05-15 | Amedrix Gmbh | Kit, dessen Verwendung und Verfahren zum Auffüllen von Bindegewebe der Haut |
CN105274049B (zh) * | 2015-11-03 | 2018-01-09 | 中山大学中山眼科中心 | 一种诱导人iPSc源性的3D视网膜定向分化为视网膜神经节细胞的方法 |
CA3055914A1 (en) * | 2017-03-09 | 2018-09-13 | Georgia Tech Research Corporation | Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury |
EP3666298A1 (de) * | 2018-12-13 | 2020-06-17 | Global Stem Cell Technology | Zur injektion geeignete kollagenformulierung |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994024298A1 (fr) * | 1993-04-21 | 1994-10-27 | Institut Pasteur | Implant biocompatible pour l'expression et secretion in vivo du compose therapeutique |
AU713375B2 (en) * | 1995-10-25 | 1999-12-02 | Kubota Corporation | Process for producing entomopathogenic nematode preparation and entomopathogenic nematode insecticide |
US5965125A (en) * | 1995-10-25 | 1999-10-12 | Transkaryotic Therapies, Inc. | Hybrid matrix implants and explants |
-
2000
- 2000-10-04 AT AT00968669T patent/ATE284674T1/de not_active IP Right Cessation
- 2000-10-04 TR TR2002/00897T patent/TR200200897T2/xx unknown
- 2000-10-04 EP EP00968669A patent/EP1221937B1/de not_active Expired - Lifetime
- 2000-10-04 WO PCT/US2000/027362 patent/WO2001024842A2/en active IP Right Grant
- 2000-10-04 CN CNB008136998A patent/CN1214781C/zh not_active Expired - Fee Related
- 2000-10-04 MX MXPA02001450A patent/MXPA02001450A/es active IP Right Grant
- 2000-10-04 JP JP2001527841A patent/JP2003511100A/ja active Pending
- 2000-10-04 DE DE60016775T patent/DE60016775D1/de not_active Expired - Lifetime
- 2000-10-04 IL IL14896200A patent/IL148962A0/xx unknown
- 2000-10-04 CA CA002379971A patent/CA2379971A1/en not_active Abandoned
- 2000-10-04 BR BR0014503-3A patent/BR0014503A/pt not_active Application Discontinuation
- 2000-10-04 AU AU78545/00A patent/AU777833B2/en not_active Ceased
- 2000-10-04 NZ NZ518759A patent/NZ518759A/en unknown
-
2002
- 2002-12-05 HK HK02108845.8A patent/HK1047240B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1221937B1 (de) | 2004-12-15 |
CN1214781C (zh) | 2005-08-17 |
AU777833B2 (en) | 2004-11-04 |
IL148962A0 (en) | 2002-11-10 |
HK1047240B (zh) | 2005-06-24 |
ATE284674T1 (de) | 2005-01-15 |
BR0014503A (pt) | 2002-06-11 |
WO2001024842A2 (en) | 2001-04-12 |
HK1047240A1 (en) | 2003-02-14 |
MXPA02001450A (es) | 2002-08-30 |
JP2003511100A (ja) | 2003-03-25 |
AU7854500A (en) | 2001-05-10 |
TR200200897T2 (tr) | 2002-08-21 |
EP1221937A2 (de) | 2002-07-17 |
CA2379971A1 (en) | 2001-04-12 |
NZ518759A (en) | 2004-10-29 |
WO2001024842A3 (en) | 2001-08-30 |
CN1377257A (zh) | 2002-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE284674T1 (de) | Hybride matrizen und gemische davon | |
Lombaert et al. | Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids | |
Ting et al. | In vitro prefabrication of human cartilage shapes using fibrin glue and human chondrocytes | |
Agarwal et al. | Oxygen releasing materials: towards addressing the hypoxia-related issues in tissue engineering | |
Hashemi et al. | Application of encapsulation technology in stem cell therapy | |
Seliktar | Extracellular stimulation in tissue engineering | |
Lamme et al. | Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation | |
NZ321417A (en) | An implantable device having a body matrix made of insoluble collagen fibrils and disposed in vertebrate cells and microspheres | |
DE69435096D1 (de) | Zusammensetzung zur in vivo erzeugung von therapeutischen produkten | |
Haagdorens et al. | In vitro cultivation of limbal epithelial stem cells on surface‐modified crosslinked collagen scaffolds | |
ATE110108T1 (de) | Genetische modifizierung von endothelialen zellen. | |
ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
HRP20040347B1 (en) | Keratynocites which may be used as biologically active substances for the treatment of wounds | |
AU2002345691A1 (en) | In vivo bioreactors | |
WO2002101385A1 (en) | In vivo bioreactors | |
ATE309007T1 (de) | Transplantate für die wiederherstellung von osteochondralen schäden | |
JPS59192364A (ja) | 軟骨および骨の修復方法 | |
BR0009562A (pt) | arpe- 19 como uma linhagem de célula de plataforma para liberação com base em célula encapsulada | |
RU2006146795A (ru) | Композиция для стимулирования роста и регенерации клеток, а также способы ее получения | |
CN106474560A (zh) | 一种用于3d生物打印的水凝胶材料及其制备方法与应用 | |
IL133428A0 (en) | Hyaluronic acid derivative based cell culture and biodegradable three-dimensional matrix | |
Santos Jr et al. | Vero cell growth and differentiation on poly (l‐lactic acid) membranes of different pore diameters | |
DE69624937D1 (de) | Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen | |
DE69817180D1 (de) | Zns neuroregenerative zusammensetzungen und deren verwendungen | |
ATE268182T1 (de) | Transplantations/implantatsvorrichtung und ihre herstellungsmethode |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |